Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 02/06/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 02/06/20 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/06/20 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
4 | |
| 02/06/20 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
238 | |
| 02/05/20 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
31 | |
| 02/05/20 | 8-K | Current report filing |
|
36 | |
| 02/04/20 | SEC STAFF LETTER |
|
2 | ||
| 01/29/20 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
4 | |
| 01/29/20 | 8-K | Current report filing |
|
6 | |
| 01/24/20 | UPLOAD | SEC-generated letter |
|
1 |
